Why we need CER

by rcentor on May 20, 2009

New Drugs Have Allure, Not Track Record
 

This article gives a wonderful explication of influence of new drugs and their high costs.

{ 1 comment… read it below or add one }

Bohdan A. Oryshkevich, MD, MPH May 20, 2009 at 12:25 pm

This is a great point and a great article.

But we need much more than that. There has to be discipline and peer pressure within the profession to do the right thing. It simply is not there.

Did they not show that Hctz was the best choice for first line hypertension therapy? Where did that go?

Bohdan A. Oryshkevich, MD, MPH

Leave a Comment

Previous post:

Next post: